Auxly Cannabis Financials
| CBWTF Stock | USD 0.02 0 6.52% |
With this module, you can analyze Auxly financials for your investing period. You should be able to track the changes in Auxly Cannabis individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Auxly |
Understanding current and past Auxly Cannabis Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Auxly Cannabis' financial statements are interrelated, with each one affecting the others. For example, an increase in Auxly Cannabis' assets may result in an increase in income on the income statement.
The data published in Auxly Cannabis' official financial statements typically reflect Auxly Cannabis' business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Auxly Cannabis' quantitative information. For example, before you start analyzing numbers published by Auxly accountants, it’s essential to understand Auxly Cannabis' liquidity, profitability, and earnings quality within the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Auxly Cannabis' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Auxly Cannabis' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Auxly Cannabis' management manipulating its earnings.
Auxly Cannabis Stock Summary
Auxly Cannabis competes with LivaNova PLC, Electromed, Orthopediatrics Corp, SurModics, and Neuropace. Auxly Cannabis Group Inc. operates as a consumer-packaged goods company in the cannabis products market in Canada. Auxly Cannabis Group Inc. was incorporated in 1987 and is based in Toronto, Canada. Cannabis Wheaton operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 558 people.| Instrument | USA OTC Stock View All |
| Exchange | OTCQX Exchange |
| ISIN | CA05335P1099 |
| Business Address | 777 Richmond Street |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | auxly.com |
| Phone | 647 812 0121 |
| Currency | USD - US Dollar |
Auxly Cannabis Key Financial Ratios
There are many critical financial ratios that Auxly Cannabis' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Auxly Cannabis Group reports annually and quarterly.| Return On Equity | -0.81 | |||
| Return On Asset | -0.0868 | |||
| Number Of Employees | 558 | |||
| Beta | 0.77 |
Auxly Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Auxly Cannabis's current stock value. Our valuation model uses many indicators to compare Auxly Cannabis value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Auxly Cannabis competition to find correlations between indicators driving Auxly Cannabis's intrinsic value. More Info.Auxly Cannabis Group is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Auxly Cannabis' earnings, one of the primary drivers of an investment's value.Auxly Cannabis Group Systematic Risk
Auxly Cannabis' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Auxly Cannabis volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fifty with a total number of output elements of eleven. The Beta measures systematic risk based on how returns on Auxly Cannabis Group correlated with the market. If Beta is less than 0 Auxly Cannabis generally moves in the opposite direction as compared to the market. If Auxly Cannabis Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Auxly Cannabis Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Auxly Cannabis is generally in the same direction as the market. If Beta > 1 Auxly Cannabis moves generally in the same direction as, but more than the movement of the benchmark.
Auxly Cannabis June 13, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Auxly Cannabis help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Auxly Cannabis Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of Auxly Cannabis Group based on widely used predictive technical indicators. In general, we focus on analyzing Auxly OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Auxly Cannabis's daily price indicators and compare them against related drivers.
| Downside Deviation | 7.89 | |||
| Information Ratio | 0.1238 | |||
| Maximum Drawdown | 91.52 | |||
| Value At Risk | (12.00) | |||
| Potential Upside | 13.64 |
Complementary Tools for Auxly OTC Stock analysis
When running Auxly Cannabis' price analysis, check to measure Auxly Cannabis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Auxly Cannabis is operating at the current time. Most of Auxly Cannabis' value examination focuses on studying past and present price action to predict the probability of Auxly Cannabis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Auxly Cannabis' price. Additionally, you may evaluate how the addition of Auxly Cannabis to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |